Cetera Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $5.82M | Buy |
13,912
+5,390
| +63% | +$2.25M | 0.05% | 407 |
|
2023
Q4 | $3.47M | Buy |
8,522
+1,568
| +23% | +$638K | 0.05% | 359 |
|
2023
Q3 | $2.42M | Sell |
6,954
-201
| -3% | -$69.9K | 0.04% | 404 |
|
2023
Q2 | $2.52M | Buy |
7,155
+212
| +3% | +$74.6K | 0.04% | 398 |
|
2023
Q1 | $2.19M | Sell |
6,943
-2,076
| -23% | -$654K | 0.04% | 416 |
|
2022
Q4 | $2.6M | Buy |
9,019
+1,010
| +13% | +$292K | 0.05% | 380 |
|
2022
Q3 | $2.32M | Buy |
8,009
+2,985
| +59% | +$864K | 0.06% | 327 |
|
2022
Q2 | $1.42M | Sell |
5,024
-287
| -5% | -$80.9K | 0.03% | 474 |
|
2022
Q1 | $1.39M | Buy |
5,311
+95
| +2% | +$24.8K | 0.03% | 505 |
|
2021
Q4 | $1.15M | Sell |
5,216
-12,737
| -71% | -$2.8M | 0.02% | 554 |
|
2021
Q3 | $3.26M | Sell |
17,953
-10,104
| -36% | -$1.83M | 0.06% | 296 |
|
2021
Q2 | $5.66M | Buy |
28,057
+23,172
| +474% | +$4.67M | 0.13% | 162 |
|
2021
Q1 | $1.05M | Buy |
4,885
+42
| +0.9% | +$9.03K | 0.03% | 464 |
|
2020
Q4 | $1.15M | Buy |
4,843
+642
| +15% | +$152K | 0.04% | 386 |
|
2020
Q3 | $1.14M | Sell |
4,201
-15
| -0.4% | -$4.08K | 0.04% | 351 |
|
2020
Q2 | $1.22M | Buy |
4,216
+1,678
| +66% | +$487K | 0.05% | 317 |
|
2020
Q1 | $604K | Buy |
2,538
+92
| +4% | +$21.9K | 0.03% | 422 |
|
2019
Q4 | $533K | Buy |
2,446
+18
| +0.7% | +$3.92K | 0.02% | 545 |
|
2019
Q3 | $412K | Buy |
2,428
+8
| +0.3% | +$1.36K | 0.02% | 603 |
|
2019
Q2 | $445K | Sell |
2,420
-91
| -4% | -$16.7K | 0.02% | 594 |
|
2019
Q1 | $462K | Buy |
2,511
+119
| +5% | +$21.9K | 0.02% | 516 |
|
2018
Q4 | $397K | Sell |
2,392
-1,430
| -37% | -$237K | 0.02% | 542 |
|
2018
Q3 | $739K | Buy |
3,822
+641
| +20% | +$124K | 0.04% | 438 |
|
2018
Q2 | $541K | Buy |
3,181
+4
| +0.1% | +$680 | 0.03% | 489 |
|
2018
Q1 | $517K | Buy |
+3,177
| New | +$517K | 0.03% | 464 |
|